Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | NAAA | Q02083 | 1/20 | 0.32 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5866441 | 1.00 | ALDH1A1 (0.36) | ALDH1A1TDP1NAAAGLO1TRPA1 | |
| SCHEMBL15255052 | 0.98 | ALDH1A1 (0.35) | ALDH1A1TDP1NAAAGLO1TRPA1 | |
| SCHEMBL4372085 | 0.85 | ALDH1A1 (0.40) | ALDH1A1TDP1TSHR | |
| SCHEMBL5138047 | 0.81 | TSHR (0.37) | ALDH1A1LMNATSHR | |
| SCHEMBL1902884 | 0.81 | — | — | |
| SCHEMBL27902952 | 0.81 | MGAM (0.48) | ALDH1A1TDP1TRPA1 | |
| SCHEMBL17181554 | 0.81 | ALDH1A1 (0.33) | ALDH1A1TDP1NAAAGLO1TRPA1 | |
| SCHEMBL8620268 | 0.81 | MGAM (0.32) | LMNA | |
| SCHEMBL432664 | 0.81 | ALDH1A1 (0.39) | ALDH1A1TDP1TRPA1LMNAHSD17B10 | |
| SCHEMBL15101930 | 0.81 | ALDH1A1 (0.39) | ALDH1A1TDP1TRPA1LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040106808-A1 | Processes for preparing calanolide a and intermediates thereof | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 2004-06-03 | — | — | US | disclosed |
| EP-1352907-A1 | PROCESSES FOR PREPARING CALANOLIDE A AND INTERMEDIATES THEREOF | KURARAY CO., LTD. (JP) | 2003-10-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040106808-A1 | Processes for preparing calanolide a and intermediates thereof | CALR, CYP51A1, CYP4A11 | ALDH1A1 1043/4885TDP1 4180/4885NAAA 2489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.